Stage 1 clinical trials are this way by design. Drugs passing stage 1 are then given to larger groups of people for stage 2 trials in which efficacy is tested. After that step, stage 3 trials are open to an even larger group, often enrolling subjects at doctors' offices, clinics, and research centers nationwide. Stage 3 compares an experimental treatment directly against the currently standard treatment.